The U.S. Food and Drug Administration (FDA) now permits the adoption of laboratory animals no longer needed for research. This policy shift is a major win for animal welfare advocates.
Each year, millions of animals worldwide are used in testing new molecules. While these studies raise ethical concerns, they have been essential to advancing medical research, allowing scientists to evaluate drug and vaccine effects before human trials.
Animal models help researchers assess how quickly treatments are absorbed, how long effects last, and identify potential toxic side effects—while also monitoring how those effects resolve.
Previously in the U.S., healthy animals were routinely euthanized after experiments, despite their contributions to science. Thankfully, practices are evolving.
Researchers have developed neurotoxin testing methods that avoid euthanasia, and others are exploring virtual models to replace live animals.
In November, the FDA officially authorized adoption of former lab animals, including dogs, cats, rabbits, guinea pigs, and certain farm animals—provided they remain healthy. The announcement was low-key at first but has now been formalized.
The FDA aligns with the National Institutes of Health, which adopted a similar policy last August, and the Department of Veterans Affairs, which encouraged lab dog adoptions two years ago. Several states have supportive laws, but this marks a key national step.
“There is no reason why regulated research animals suitable for adoption or retirement should be killed by our federal agencies,” said Maine Senator Susan Collins, who introduced protective legislation last year. “I am pleased that the FDA has joined the NIH and VA in promulgating a laboratory animal retirement policy.”
Europe's 2010 directive similarly allows release or rehoming of lab animals into suitable environments, though capacity issues limit uptake. Learn more here.
Related articles:
